Evidence map›Paper›PMID 41477386›Full record

ArticleCureus2025

A Rapidly Growing Desmoid Tumor of the Anterior Chest Wall in a Young Woman: A Case Report.

Juan J Villamarín, Ana M Rendón-Garavito, Andres Francisco Vasquez Perdomo, Angela Moreno

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juan J VillamarínDepartment of Radiology, Universidad de La Sabana, Chía, COL.
Ana M Rendón-GaravitoDepartment of Radiology, Fundación Santa Fe de Bogotá, Bogotá, COL.
Andres Francisco Vasquez PerdomoDepartment of Radiology, Fundación Santa Fe de Bogotá, Bogotá, COL.
Angela MorenoDepartment of Radiology, Fundación Santa Fe de Bogotá, Bogotá, COL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Desmoid tumors (DTs), or aggressive fibromatosis, are rare fibroblastic neoplasms of connective tissue origin. They are locally invasive with a high rate of recurrence, although metastasis is rare. Their clinical behavior varies widely, as some tumors exhibit progressive growth, while others remain stable or may spontaneously regress. Symptoms depend largely on tumor size and location. We present the case of a 25-year-old woman who developed a painful, enlarging mass in the right breast region over two months. Imaging revealed a 100 × 60 mm lesion involving intrathoracic structures and musculature, located posterior to a breast implant. Core needle biopsy confirmed an extra-abdominal DT of the anterior chest wall. Taking into account the symptom severity and rapid tumor progression, the patient underwent surgical resection with chest wall reconstruction using polypropylene mesh and titanium rib prostheses. Postoperative imaging showed complete resection, and the patient remained free of recurrence at two, four, and five years of follow-up. While conservative management with surveillance is increasingly recommended for stable DTs, surgery remains the primary treatment for symptomatic or fast-growing tumors, although new non-invasive methods are on the rise. Accurate diagnosis requires a combination of imaging and histopathological confirmation, and long-term follow-up is essential because of the risk of recurrence. This case highlights that early and complete surgical management, combined with appropriate reconstruction, can lead to favorable long-term outcomes and improved patient quality of life.

Indexed as

breastbreast implantsclinical case reportdesmoid tumorsrib resectionsurgical case reports

Identifiers

PMID41477386
PMCPMC12753126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.